Hinge Health, Inc. (HNGE) Q2 FY26 Earnings Call

Strong core execution and rising yield support higher 2026 guidance, while GI expansion adds integration and near-term loss risk.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Length66 minutes
EPS$0.66
EPS consensus$0.28

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Read the full Q2 FY26 earnings call transcript

All HNGE earnings · Back to HNGE overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.